 Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why 
The world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated billions of shares. Bill Gates sold 500,000 shares of Microsoft. Jeff Bezos filed to sell Amazon shares worth $4.8 billion. What is going on? One multi-millionaire believes they are preparing for a catastrophic event. But not a crash, bank run, or recession. It’s something we haven’t seen in America for more than a century. For the full story, click here.
This Week's Featured Article Rocket Lab's Neutron Hiccup Sparked a Sell-Off—Overreaction or Omen?Reported by Ryan Hasson. Article Published: 2/10/2026. 
Key Takeaways- Rocket Lab has entered bear-market territory, driven by short-term uncertainty around Neutron testing and headlines about government funding.
- The broader uptrend remains intact, with shares holding above the 200-day moving average and showing signs of stabilization near the 50-day SMA.
- Wall Street remains bullish, with rising price targets and analysts viewing recent setbacks as routine development noise ahead of key catalysts.
Shares of Rocket Lab Corporation (NASDAQ: RKLB), one of the fastest-growing names in the aerospace and defense sector, have come under pressure. The stock is down nearly 10% for the month and more than 20% from its January record highs. As of the market close on Monday, Feb. 9, shares were off almost 24% from their peak, technically placing the stock in bear market territory. The pullback marks a clear shift in momentum after an exceptional run. It also raises an important question for long-term investors: Has the growth story fundamentally changed, or is this simply a routine reset within a much larger uptrend? What Triggered the Pullback?The initial catalyst came in January, when Rocket Lab disclosed that a Stage 1 tank ruptured during qualification testing at its Long Beach, California, facility. Although the headline spooked markets, Rocket Lab noted that such outcomes are not uncommon during development testing. The company confirmed there was no damage to surrounding facilities and that a replacement Stage 1 tank is already in production. Importantly, Neutron's development program remains active. Still, uncertainty about whether the incident could cause another delay for Neutron's maiden flight weighed on sentiment. Rocket Lab said it would assess the impact and provide an updated timeline on its fourth-quarter earnings call later this month, leaving investors without immediate clarity. More recently, shares faced additional pressure after Congress declined to fund a planned 2031 Mars sample-return mission. That headline reignited concerns about visibility into long-term government funding, adding to the negative news flow. After a massive multi-year rally—RKLB surged more than 1,300% over three years—and with the stock extremely overbought earlier this year, some profit-taking was inevitable once sentiment shifted. The Bigger Trend Remains IntactDespite the recent volatility, Rocket Lab's broader technical structure remains constructive. The stock has pulled back toward its rising 50-day simple moving average and, so far, appears to be finding support in the low-to-mid $70s. That price action suggests a potential higher low within its longer-term uptrend. Crucially, shares remain well above the 200-day moving average, a key indicator that the primary trend is still intact. Even after the correction, Rocket Lab is positive year-to-date, underscoring how strong the underlying move has been. Other space-related stocks have experienced similar pullbacks in recent weeks, pointing more toward sector-wide consolidation than company-specific deterioration. With investor enthusiasm around the space economy still elevated and speculation about a potential SpaceX IPO later this year, interest in the sector remains strong. From a technical standpoint, the picture would materially weaken only if RKLB fell below its 50-day moving average and drifted toward its 200-day moving average. For now, that scenario has not played out. Wall Street Remains SupportiveAnalyst sentiment has remained notably resilient throughout the pullback. Rocket Lab currently carries a consensus Moderate Buy rating, and price targets have continued to move higher. Three months ago, the consensus target sat near $57; as of early February, it had climbed to almost $73. Several analysts characterized the Neutron testing issue as a routine part of launch-vehicle development rather than a fundamental setback. Bank of America reiterated its Buy rating, while TD Cowen echoed confidence in Neutron's long-term potential, emphasizing that no facility damage occurred and replacement hardware is already underway. Looking ahead, Rocket Lab's upcoming earnings report will be a key inflection point. Investors will focus on updates to Neutron's launch timeline, progress on vertical integration, margin trends, and the company's growing backlog. For now, the recent pullback appears less like the end of the story and more like a pause—one that long-term, risk-tolerant investors may view as an opportunity rather than a warning sign.
This ad is sent on behalf of Banyan Hill Publishing. P.O. Box 8378, Delray Beach, FL 33482. | 
No comments:
Post a Comment